BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7547503)

  • 1. FGF-8 isoforms differ in NIH3T3 cell transforming potential.
    MacArthur CA; Lawshé A; Shankar DB; Heikinheimo M; Shackleford GM
    Cell Growth Differ; 1995 Jul; 6(7):817-25. PubMed ID: 7547503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and characterization of human FGF8 alternative messenger RNA forms.
    Ghosh AK; Shankar DB; Shackleford GM; Wu K; T'Ang A; Miller GJ; Zheng J; Roy-Burman P
    Cell Growth Differ; 1996 Oct; 7(10):1425-34. PubMed ID: 8891346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells.
    Mattila MM; Ruohola JK; Valve EM; Tasanen MJ; Seppänen JA; Härkönen PL
    Oncogene; 2001 May; 20(22):2791-804. PubMed ID: 11420691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
    Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological significance of the hst-1 gene.
    Terada M; Yoshida T; Sakamoto H; Miyagawa K; Katoh O; Hattori Y; Sugimura T
    Princess Takamatsu Symp; 1989; 20():71-80. PubMed ID: 2535108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming activity of a newly cloned androgen-induced growth factor.
    Kouhara H; Koga M; Kasayama S; Tanaka A; Kishimoto T; Sato B
    Oncogene; 1994 Feb; 9(2):455-62. PubMed ID: 8290257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts.
    Caruana G; Cambareri AC; Ashman LK
    Oncogene; 1999 Sep; 18(40):5573-81. PubMed ID: 10523834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis.
    Jeffers M; Shimkets R; Prayaga S; Boldog F; Yang M; Burgess C; Fernandes E; Rittman B; Shimkets J; LaRochelle WJ; Lichenstein HS
    Cancer Res; 2001 Apr; 61(7):3131-8. PubMed ID: 11306498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hst-2 (FGF-6) oncogene: cDNA cloning and characterization.
    Iida S; Yoshida T; Naito K; Sakamoto H; Katoh O; Hirohashi S; Sato T; Onda M; Sugimura T; Terada M
    Oncogene; 1992 Feb; 7(2):303-9. PubMed ID: 1549352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and functional analysis of a novel cadmium-responsive proto-oncogene.
    Joseph P; Lei YX; Whong WZ; Ong TM
    Cancer Res; 2002 Feb; 62(3):703-7. PubMed ID: 11830523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-1-inducible gene FR-17 encodes a nonmuscle alpha-actinin isoform.
    Hsu DK; Guo Y; Alberts GF; Peifley KA; Winkles JA
    J Cell Physiol; 1996 May; 167(2):261-8. PubMed ID: 8613466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
    Shain SA; Sarić T; Ke LD; Nannen D; Yoas S
    Cell Growth Differ; 1996 May; 7(5):573-86. PubMed ID: 8732667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell transformation by Int-2--a member of the fibroblast growth factor family.
    Goldfarb M; Deed R; MacAllan D; Walther W; Dickson C; Peters G
    Oncogene; 1991 Jan; 6(1):65-71. PubMed ID: 1846956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.
    Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H
    Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line.
    Maret A; Galy B; Arnaud E; Bayard F; Prats H
    Cancer Res; 1995 Nov; 55(21):5075-9. PubMed ID: 7585554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of fibroblast growth factor-4 does not alter the growth or the differentiation of embryonal carcinoma cells.
    Miller K; Rizzino A
    Cell Growth Differ; 1996 Feb; 7(2):203-11. PubMed ID: 8822204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of expression of growth-related genes by FGF-4 in mouse fibroblasts.
    Guthridge MA; Seldin M; Basilico C
    Oncogene; 1996 Mar; 12(6):1267-78. PubMed ID: 8649829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression cloning, developmental expression and chromosomal localization of fibroblast growth factor-8.
    Lorenzi MV; Long JE; Miki T; Aaronson SA
    Oncogene; 1995 May; 10(10):2051-5. PubMed ID: 7761105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.